These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34454405)

  • 1. Evidence for Reversal of Immunosuppression by Homeopathic Medicine to a Predominant Th1-type Immune Response in BALB/c Mice Infected with Leishmania donovani.
    Joshi J; Bandral C; Manchanda RK; Khurana A; Nayak D; Kaur S
    Homeopathy; 2022 Feb; 111(1):31-41. PubMed ID: 34454405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Iodium 30c on Experimental Visceral Leishmaniasis.
    Joshi J; Bandral C; Manchanda RK; Khurana A; Nayak D; Kaur S
    Homeopathy; 2020 Nov; 109(4):213-223. PubMed ID: 32823292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa.
    Das A; Jawed JJ; Das MC; Sandhu P; De UC; Dinda B; Akhter Y; Bhattacharjee S
    Int J Antimicrob Agents; 2017 Oct; 50(4):512-522. PubMed ID: 28669838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB/c mice.
    Das A; Jawed JJ; Das MC; Parveen S; Ghosh C; Majumdar S; Saha B; Bhattacharjee S
    Cytokine; 2021 Jan; 137():155319. PubMed ID: 33002744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential of Quercetin-Loaded Nanoemulsion against Experimental Visceral Leishmaniasis:
    Das SS; Dubey AK; Verma PRP; Singh SK; Singh SK
    Mol Pharm; 2022 Sep; 19(9):3367-3384. PubMed ID: 35980291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12.
    Adhikari A; Gupta G; Majumder S; Banerjee S; Bhattacharjee S; Bhattacharya P; Kumari S; Haldar S; Majumdar SB; Saha B; Majumdar S
    PLoS One; 2012; 7(7):e40265. PubMed ID: 22792256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
    Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
    mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant effects of TLR agonist gardiquimod admixed with Leishmania vaccine in mice model of visceral leishmaniasis.
    Goyal DK; Keshav P; Kaur S
    Infect Genet Evol; 2021 Sep; 93():104947. PubMed ID: 34052416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
    Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
    Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
    Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
    Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection.
    Bhattacharjee S; Bhattacharjee A; Majumder S; Majumdar SB; Majumdar S
    J Antimicrob Chemother; 2012 Aug; 67(8):1905-14. PubMed ID: 22589456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct evidence for role of anti-saliva antibodies against salivary gland homogenate of P. argentipes in modulation of protective Th1-immune response against Leishmania donovani.
    Pushpanjali ; Thakur AK; Purkait B; Jamal F; Singh MK; Ahmed G; Bimal S; Kumar V; Singh SK; Keshri S; Das P; Narayan S
    Cytokine; 2016 Oct; 86():79-85. PubMed ID: 27484246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis.
    Amit A; Chaudhary R; Yadav A; Suman SS; Narayan S; Das VN; Pandey K; Singh SK; Singh BK; Ali V; Das P; Bimal S
    Cell Immunol; 2014; 289(1-2):76-85. PubMed ID: 24732062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice.
    Thakur A; Kaur H; Kaur S
    Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis.
    Want MY; Islamuddin M; Chouhan G; Ozbak HA; Hemeg HA; Dasgupta AK; Chattopadhyay AP; Afrin F
    Colloids Surf B Biointerfaces; 2015 Jun; 130():215-21. PubMed ID: 25936561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.